Premium
Topiramate for Migraine Prophylaxis Among Chinese Population
Author(s) -
Li Ho Lun,
Kwan Patrick,
Leung Howan,
Yu Evelyn,
Tsoi Tak Hong,
Hui Andrew Che Fai,
Sheng Bun,
Lau Kwok Kwong
Publication year - 2007
Publication title -
headache: the journal of head and face pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 119
eISSN - 1526-4610
pISSN - 0017-8748
DOI - 10.1111/j.1526-4610.2007.00763_3.x
Subject(s) - topiramate , migraine , medicine , observational study , chinese population , multicenter study , anesthesia , population , prophylactic treatment , pediatrics , randomized controlled trial , psychiatry , epilepsy , biochemistry , chemistry , environmental health , genotype , gene
We evaluated the efficacy and safety of topiramate for migraine prophylaxis among Chinese patients in a multicenter prospective observational study. We found that topiramate at low doses was effective in preventing migraine headache in Chinese patients and was generally well tolerated. There was no difference in baseline headache frequency or intensity between responders and nonresponders.